| Study Period | 2021 - 2032 |
| Market Size in 2025 | USD 18.6 Billion |
| Market Size in 2026 | USD 19.4 Billion |
| Market Size by 2032 | USD 26.1 Billion |
| Projected CAGR | 5% |
| Largest Country | U.S. |
| Fastest-Growing Country | Canada |
| Market Structure | Semi-Consolidated |
Explore the market potential with our data-driven report
The North American diagnostic imaging systems market size was USD 18.6 billion for 2025, and it will grow by 5.0% during 2026–2032, to reach USD 26.1 billion by 2032.
The major factors that have contributed to an increase in diagnostic imaging systems demand are increasing incidence of chronic illness, the increasing number of elderly populations, increased use of new and improved technology i.e., computed tomography and magnetic resonance imaging, and the growing use of artificial intelligence-enabled diagnostic systems.
The demand for early detection and prevention of diseases is significantly changing the diagnostic imaging space within North America. The Centers for Disease Control and Prevention report that in 2023, 194 million American adults had at least one chronic condition, and because the population will be aging, the need for these types of diagnostics will grow. Also, the health care infrastructure in North America is among the best in the world and the region has the highest per capita expenditures on health care of all regions worldwide.
Therefore, the combination of the disease burden, infrastructure and costs provide the environment in which North America is the largest segment of the global diagnostic imaging systems market. Additionally, the American College of Radiology reports that the U.S. alone conducts over 300 million diagnostic imaging studies each year. Another major factor contributing to the growth of the diagnostic imaging systems market is the integration of artificial intelligence and machine learning into the workflow of diagnostic imaging systems.
As of recent FDA disclosures (2024–2025), over 1,300 medical devices utilize AI, and radiology represent about 80% of those clearances. The integration of AI and machine learning into diagnostic imaging systems will help address two of the most significant issues facing the healthcare system today, i.e., the growing shortage of radiologists and the increasing volume of images being produced.
The diagnostic imaging systems market is also supported by the substantial amounts of money spent on health care in North America. In 2023, the United States spent USD 4.9 trillion on health care, 17.6% of its Gross Domestic Product (GDP). The expenditures made by the government for health care services and the government's payment for health care services have provided a financial foundation for the development and application of new and improved technologies for diagnostic imaging.
The X-ray category holds the largest market share, of 40%, in 2025, because it is used so widely as a primary modality of diagnosis, and it has much less cost than other forms of diagnostic imaging both in terms of initial capital investment and ongoing operational expenses. It is fast at acquiring images and can be performed on a wide variety of patients, which are common in hospitals, diagnostic imaging centers, and outpatient settings.
The magnetic resonance imaging (MRI) category will have the highest CAGR, of 5.1%, because of its better ability to provide soft tissue contrast compared to other modalities; there are no ionizing radiations; and it has a growing number of clinical applications in neurology, oncology, and musculoskeletal imaging. Furthermore, the advancement of new MRI technologies, such as 3-T and 7-T systems and AI-enhanced image reconstruction software are continuing to improve the capability of MRI to diagnose patients' conditions faster, with reduced scanning times and improved patient comfort.
The product types analyzed in this report are:
The cardiology category holds the largest market share, in 2025, primarily because cardiovascular diseases have the highest incidence rate and continue to be the number one cause of death in North America. As per the DCD, cardiovascular disease is the primary cause of mortality among men, women, and individuals from various racial and ethnic backgrounds. Every 34 seconds, an individual succumbs to cardiovascular disease. In the year 2023, there were 919,032 fatalities attributed to cardiovascular disease, which translates to 1 in every 3 deaths.
Cardiac imaging technologies like cardiac CT angiography, cardiac MRI and nuclear cardiology provide non-invasive evaluations for coronary artery disease, heart failure, and valvular disease. In addition, the use of artificial intelligence (AI) algorithms to perform coronary artery calcium scoring automatically, and to calculate fractional flow reserve from CT angiography images, improves the diagnostic capabilities of these imaging modalities, and reduces the need for invasive procedures.
The oncology category will have the highest CAGR, due to increasing incidence rates of cancer and the essential role imaging plays in cancer screening, diagnosis, staging, and monitoring. As per the American Cancer Society, excluding non-melanoma skin cancers, it is anticipated that over 2 million new cancer cases will be diagnosed in the US in 2025, with more than 618,000 individuals expected to succumb to the disease, which translates to approximately 1,700 deaths each day.
Increased imaging volume in oncology is being experienced due to the nationwide introduction of screening programs for breast, lung and colon cancers. Many of the latest imaging technologies for cancer, including PET-CT for metabolic imaging, MRI for soft tissue characterization, and AI powered image analysis for lesion detection and characterization are rapidly becoming standard of care practices for oncologists. Radiomics and imaging biomarkers that can predict treatment response and patient outcomes are another developing technology that will expand this segment even further.
The diagnostic imaging analyzed in this report are:
The hospitals category holds the largest market share, of 60%, in 2025, due to the fact that hospitals are able to provide complete diagnostic services and manage the complexity of medical conditions through their imaging department. Hospitals have the financial resources to invest in top-of-the-line diagnostic imaging technology (e.g., 3T MRI machines, advanced CT scanners, hybrid imaging platforms). In addition, as stated by the American Hospital Association, the majority of emergency and in-patient imaging procedures occur within hospital walls. Additionally, hospitals operate 24/7 to address urgent issues related to trauma, stroke, and acute care; therefore, their ability to be available for emergency situations is crucial. Furthermore, hospitals are well-equipped to support multidisciplinary groups of radiologists, technologists, and support staff, thereby optimizing the use of all imaging technologies.
The diagnostic imaging centers category will have the highest CAGR, of 5.3%, due to the increasing trend towards outpatient care and the desire by patients and payers for value-based care options. Additionally, many of these imaging centers offer shorter waiting periods, flexible scheduling, and specialize in certain types of imaging modalities, leading to higher levels of patient satisfaction. Imaging centers are also employing advanced technologies to remain competitive with hospital-based imaging departments (e.g., AI-optimized workflow solutions and cloud-based image management systems) while continuing to maintain lower overhead costs.
The end users analyzed in this report are:
Drive strategic growth with comprehensive market analysis
The U.S. holds the larger market share, of 45%, in 2025, Diagnostic Imaging Systems Market Size in the U.S., due to the superior quality of the U.S. health care system, the large expenditures for health care within the U.S., and the quick rate of adoption of new technologies in the field of diagnostic imaging. The U.S. has an active technology advancement environment and is the leader in the adoption of AI into medical imaging. As reported by the Food & Drug Administration, the majority of AI-enabled medical devices that have been approved for use are used in hospitals in the U.S. This demonstrates the country’s commitment to using technology to enhance the ability to diagnose patients more effectively.
The growth of the diagnostic imaging systems market in the U.S. is also being fueled by the increasing emphasis on prevention, and the early detection of diseases. The U.S. has implemented screening programs for various cancers, such as low dose computed tomography (CT) scans for individuals who are considered to be at high risk of developing lung cancer, and advanced breast imaging technologies to detect breast cancer earlier. Early detection of cancer through the use of screening programs based on imaging technology has contributed to declines in cancer-related mortality in the U.S. In addition, the growth of outpatient imaging services, including diagnostic imaging centers, has expanded patient access and convenience to diagnostic imaging, while providing cost savings relative to hospital-based imaging services.
Canada will have the higher CAGR, of 5.2%, as the Canadian healthcare system is investing a significant amount of resources in medical imaging equipment. One challenge facing the Canadian diagnostic imaging systems market is addressing geographic disparities in access to diagnostic imaging. Many rural and remote communities lack access to diagnostic imaging services. To address these challenges, the provinces are implementing innovative solutions, such as mobile imaging units, teleradiology services, and partnering with specialized imaging centers to provide diagnostic services to residents in these communities.
The adoption of artificial intelligence (AI), and other digital health technologies, is rapidly advancing, with many Canadian health care facilities now adopting AI-powered diagnostic tools to increase efficiency, and address a shortage of clinical radiologists in the country. Therefore, the adoption of technology is critical to maintain service levels. Recent investments in the modernization of health care infrastructure, and federal initiatives to support digital health transformation, are expected to continue driving growth in the Canadian diagnostic imaging systems market throughout the forecasted timeframe.
In Canada, imaging-diagnosable chronic diseases affect millions of people: 7.6% of Canadians have been diagnosed with cancer, which relies on CT, MRI, PET, and mammography for detection and monitoring. Heart disease affects 7.3% of Canadians and is routinely evaluated using echocardiography and cardiac imaging, while 3.9% have experienced a stroke, a condition almost always diagnosed with CT or MRI. The Public Health Agency of Canada’s Canadian Chronic Disease Surveillance System identifies these conditions among the country’s leading chronic diseases.
The countries studied in the market are as follows:
The market is semi-consolidated, driven by high barriers to entry into the medical imaging marketplace, such as the significant investment required for research and development of new products, the complexity of the regulatory environment, and the requirement for extensive clinical testing of each new product prior to sale. There are two types of players in this marketplace: large multinational corporations that have developed a wide range of products for multiple imaging modalities and smaller companies that specialize in a single technology or a small number of related technologies within one modality.
Market participants are increasingly partnering with artificial intelligence and healthcare information technology providers to develop integrated diagnostic solutions. While some of the newer entrants in the marketplace are developing innovative technologies, it appears difficult for new entrants to enter the marketplace and compete effectively because of the strong presence of the long-time manufacturers in the marketplace and the established service networks of those manufacturers.
Want a report tailored exactly to your business need?
Request CustomizationLeading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages